| AB Sciex (d/b/a Sciex). (9/13/17). "Press Release: Meet Sciex and Learn about Industrialized Biomarker Research Using SWATH Acquisition at HUPO 2017". Framingham, MA. |
2017-09-13 |
| Agilent Technologies Inc.. (1/9/18). "Press Release: Agilent Expands Cell Analysis Portfolio with Acquisition of Luxcel Biosciences". Santa Clara, CA. |
2018-01-09 |
| Agilent Technologies Inc.. (11/16/18). "Press Release: Agilent Expands Cell Analysis R&D Capabilities in Ireland. New Facility Incorporates Recently Acquired Luxcel Biosciences". Santa Clara, CA. |
2018-11-16 |
| Alkermes plc. (11/25/19). "Press Release: Alkermes Completes Acquisition of Rodin Therapeutics". Dublin. |
2019-11-25 |
| Almac Group Ltd.. (1/18/18). "Press Release: Almac Group Announces Further Expansion at Its European Campus in Dundalk". Craigavon. |
2018-01-18 |
| Almac Group Ltd.. (11/1/17). "Press Release: Almac Group Announces Acquisition of BioClin Laboratories". Craigavon. |
2017-11-01 |
| Almac Group Ltd.. (2/14/17). "Press Release: RCSI and Almac Discovery Enter Research Collaboration to Target Therapy-resistant Cancer Tumours". Craigavon. |
2017-02-14 |
| Almac Group Ltd.. (2/28/18). "Press Release: Almac Group Expands with Opening of £20 Million Cold Chain Facility". Craigavon. |
2018-02-28 |
| Amgen Inc.. (12/12/22). "Press Release: Rule 2.7 Announcement. Amgen Inc to Acquire Horizon Therapeutics plc". Thousand Oaks, CA. |
2022-12-12 |
| Applied Process Company Ltd. (APC Ltd.). (6/10/20). "Press Release: Irish Company APC Partners with Australian Biotechnology Firm Vaxine to Accelerate the Development and Delivery of New Covid-19 Vaccine candidate". Dublin. |
2020-06-10 |
| Argen-X N.V. (Argenx). (7/17/18). "Press Release: Argenx Receives Milestone Payment from Strategic Collaboration with Shire". Breda & Ghent. |
2018-07-17 |
| Autifony Therapeutics Ltd.. (11/14/23). "Press Release: Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders". Stevenage. |
2023-11-14 |
| Avectas Ltd.. (4/16/20). "Press Release: Avectas Completes Significant Series C Funding Bringing Total Invested Equity to Over $40 Million". Dublin. |
2020-04-16 |
| Avectas Ltd.. (4/8/20). "Press Release: Avectas Announces Issuance of U.S. Patent for Cell Engineering Technology by the U.S. Patent and Trademark Office". Dublin. |
2020-04-08 |
| Avectas Ltd.. (4/9/19). "Press Release: Avectas Raises $10 Million in Equity Finance". Ireland. |
2019-04-09 |
| Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin. |
2022-09-13 |
| BioSpecifics Technologies Corporation. (10/19/20). "Press Release: BioSpecifics to be Acquired by Endo Pharmaceuticals". Wilmington, DE. |
2020-10-19 |
| Biosynth Carbosynth. (5/25/22). "Press Release: Biosynth Carbosynth Further Expands Life Sciences Platform with Acquisition of Aalto Bio Reagents". Staad. |
2022-05-25 |
| Bruker Corporation. (9/18/17). "Press Release: Bruker Launches the timsTOF Pro Mass Spectrometer to Enable the Revolutionary PASEF Method for Next-Generation Proteomics". Dublin. |
2017-09-18 |
| BTG plc. (9/7/18). "Press Release: BTG plc Acquires Novate Medical Ltd.". |
2018-09-07 |
| c-LEcta GmbH. (2/15/22). "Press Release: c-LEcta Announces that it Has Reached Agreement to Be Acquired by Kerry Group". |
2022-02-15 |
| Carrick Therapeutics Ltd.. (11/30/17). "Press Release: Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of iIts Oral CDK7 inhibitor – CT7001". |
2017-11-30 |
| Carrick Therapeutics Ltd.. (8/30/17). "Press Release: Carrick Therapeutics Appoints Chairman as One of Two New Board Members". Dublin. |
2017-08-30 |
| Celgene Corporation. (10/21/17). "Press Release: Celgene Provides Update on GED-0301 (mongersen) Inflammatory Bowel Disease Program". Summit, NJ. |
2017-10-21 |
| Chiesi Farmaceutici S.p.A.. (1/8/23). "Press Release: Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc". Parma, Boston, MA & Dublin. |
2023-01-08 |
| Coave Therapeutics (Horama S.A.). (7/21/21). "Press Release: Coave Therapeutics Closes €33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform". Paris. |
2021-07-21 |
| Congenica Ltd.. (2/12/18). "Press Release: Congenica and SFI Research Centre FutureNeuro Unite to Deliver More Accurate Diagnoses for Genetic Epilepsy". Cambridge & Dublin. |
2018-02-12 |
| Cosmo Pharmaceuticals N.V.. (3/27/17). "Press Release: Cosmo Announces further Expansion of Endoscopy Pipeline with Filing for EU Approval of New Medical Device Qolotag to Enhance Diagnosis in Sigmoidoscopies". Dublin. |
2017-03-27 |
| Cosmo Pharmaceuticals N.V.. (6/1/17). "Press Release: Cosmo Appoints New Head of Investor Relations". Dublin. |
2017-06-01 |
| Dualyx N.V.. (5/15/23). "Press Release: Dualyx Raises €40 Million to Progress Treg Therapies for Autoimmune Diseases into the Clinic". Ghent. |
2023-05-15 |
| ECBF Management GmbH. (11/11/21). "Press Release: European Circular Bioeconomy Fund (ECBF) Invests $7 Million USD in Irish AI-discovery Platform Company Nuritas". Dublin & Luxembourg. |
2021-11-11 |
| Empyrean Neuroscience, Inc.. (10/18/22). "Press Release: Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders". New York, NY & Cambridge. |
2022-10-18 |
| Endo International plc. (4/10/17). "Press Release: Endo International plc Announces Proposed Private Offering of Senior Secured Notes". Dublin. |
2017-04-10 |
| Endo International plc. (4/12/17). "Press Release: Endo International plc Announces Pricing of Private Offering of Senior Secured Notes". Dublin. |
2017-04-12 |
| ERS Genomics Ltd.. (1/13/20). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo to Support Internal Research and Development". Dublin. |
2020-01-13 |
| ERS Genomics Ltd.. (1/17/20). "Press Release: ERS Genomics Provides Comment on EPO Technical Board of Appeal Decision Upholding Revocation of Broad Institute CRISPR Patent". Dublin. |
2020-01-17 |
| ERS Genomics Ltd.. (1/18/18). "Press Release: ERS Genomics Responds to Revocation of Broad Institute European Patent". Dublin. |
2018-01-18 |
| ERS Genomics Ltd.. (1/7/20). "Press Release: ERS Genomics Announces Agreement with New England Biolabs to Commercialize CRISPR Gene Editing Tools and Reagents". Dublin & Ipswich, MA. |
2020-01-07 |
| ERS Genomics Ltd.. (10/14/20). "Press Release: ERS Genomics Announces agreement with Fasmac to Commercialize CRISPR/Cas9 Research Reagents in Japan". Dublin & Kanagawa. |
2020-10-14 |
| ERS Genomics Ltd.. (10/16/18). "Press Release: ERS Genomics and Syngulon Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Industrial Applications". Dublin & Seraing. |
2018-10-16 |
| ERS Genomics Ltd.. (10/4/18). "Press Release: Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin. |
2018-10-04 |
| ERS Genomics Ltd.. (10/4/18). "Press Release: GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin. |
2018-10-04 |
| ERS Genomics Ltd.. (11/1/18). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to DefiniGen to Develop Human Cell Models to Support the Preclinical Development of Therapeutics". Dublin & Cambridge. |
2018-11-01 |
| ERS Genomics Ltd.. (11/10/17). "Press Release: ERS Genomics and Cellecta, Inc. Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Tools and Services". Dublin & Mountain View, CA. |
2017-11-10 |
| ERS Genomics Ltd.. (12/1/20). "Press Release: Vivlion GmbH Signs Worldwide License Agreement With ERS Genomics for CRISPR/Cas9 Patent Portfolio". Dublin & Frankfurt/M.. |
2020-12-01 |
| ERS Genomics Ltd.. (12/13/18). "Press Release: ERS Genomics and Lonza Enter into CRISPR/Cas9 Technology Licensing Deal". Dublin. |
2018-12-13 |
| ERS Genomics Ltd.. (12/5/17). "Press Release: Horizon Extends Industry-Leading Gene Editing IP Portfolio through Expansion of CRISPR License Rights with ERS Genomics". Dublin & Cambridge. |
2017-12-05 |
| ERS Genomics Ltd.. (12/6/17). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Charles River". Dublin. |
2017-12-06 |
| ERS Genomics Ltd.. (2/10/20). "Press Release: ERS Genomics Provides Comment on Affirmation of Key CRISPR-Cas9 Patent Involved in European Opposition Proceedings". Dublin. |
2020-02-10 |
| ERS Genomics Ltd.. (2/11/20). "Press Release: ERS Genomics and Aelian Biotechnology Announce CRISPR/Cas9 License Agreement Enabling Aelian’s Unique Screening Platform". Dublin & Vienna. |
2020-02-11 |
| ERS Genomics Ltd.. (2/16/21). "Press Release: ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement". Dublin & Barcelona. |
2021-02-16 |
| ERS Genomics Ltd.. (2/28/18). "Press Release: European Patent Office Grants Second Charpentier/Doudna Patent Covering CRISPR-Cas9 Gene Regulation Applications". Dublin. |
2018-02-28 |
| ERS Genomics Ltd.. (3/1/21). "Press Release: ERS Genomics Expands Team With Appointment of Jon Kratochvil as VP Business Development". Dublin. |
2021-03-01 |
| ERS Genomics Ltd.. (3/13/24). "Press Release: Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Tokyo & Dublin. |
2024-03-13 |
| ERS Genomics Ltd.. (3/26/24). "Press Release: Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual Property Administration". Dublin. |
2024-03-26 |
| ERS Genomics Ltd.. (3/3/21). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Otsuka Pharmaceutical". Dublin. |
2021-03-03 |
| ERS Genomics Ltd.. (4/2/20). "Press Release: ERS Genomics and Axxam Announce CRISPR/Cas9 License Agreement to Enhance Discovery Services". Dublin & Milan. |
2020-04-02 |
| ERS Genomics Ltd.. (4/23/19). "Press Release: US Patent Office Grants Charpentier/Doudna Key CRISPR Patent". Dublin. |
2019-04-23 |
| ERS Genomics Ltd.. (4/3/19). "Press Release: European Patent Office Grants 3rd Charpentier/Doudna Patent Covering Uses of CRISPR/cas9 in Human and Animal Cells". Dublin. |
2019-04-03 |
| ERS Genomics Ltd.. (5/2/18). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to Evotec". Dublin. |
2018-05-02 |
| ERS Genomics Ltd.. (5/31/18). "Press Release: ERS Genomics Licenses CRISPR/Cas9 Genome Editing Patents to NMI and NMI TT Pharmaservices". Dublin & Reutlingen. |
2018-05-31 |
| ERS Genomics Ltd.. (6/1/21). "Press Release: Japanese Patent Office Upholds Key Charpentier/Doudna CRISPR Patent and Allows Third". Dublin. |
2021-06-01 |
| ERS Genomics Ltd.. (6/27/17). "Press Release: DuPont Pioneer Secures Exclusive Rights to ERS Genomics’ CRISPR-Cas Patent Portfolio for Agriculture". Johnston, IA & Dublin. |
2017-06-27 |
| ERS Genomics Ltd.. (8/17/21). "Press Release: ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement". Dublin & Coralville, IA. |
2021-08-17 |
| ERS Genomics Ltd.. (9/14/20). "Press Release: ERS Genomics Provides Comment on US Patent Office Motions Decisions in CRISPR/Cas9 Interference Case". Dublin. |
2020-09-14 |
| ERS Genomics Ltd.. (9/22/20). "Press Release: ERS Genomics Appoints Michael Arciero as Vice-President of Intellectual Property & Commercial Development". Dublin. |
2020-09-22 |
| Eurofins Scientific. (2/23/18). "Press Release: Eurofins Becomes the Market Leader in Environment Testing Services in Ireland with the Acquisition of ELS and City Analysts". |
2018-02-23 |
| Euronext N.V.. (11/29/17). "Press Release: Euronext Expands Its Federal Model with the Acquisition of the Irish Stock Exchange". Amsterdam, et al.. |
2017-11-29 |
| Evotec AG. (5/2/18). "Press Release: Evotec Expands CRISPR-based Technology Offering with Licence from ERS Genomics". Hamburg. |
2018-05-02 |
| ExpreS2ion Biotech Holding AB. (7/1/19). "Press Release: ExpreS2ion Licenses Groundbreaking CRISPR/Cas9 Gene Editing Technology from ERS Genomics". |
2019-07-01 |
| FIRE1 (Foundry Innovation & Research 1, Ltd.). (1/30/18). "Press Release: FIRE1 Raises EUR 40 Million in Series C Financing". Dublin. |
2018-01-30 |
| Forbion Capital Partners. (7/20/22). "Press Release: Forbion Appoints Dr. Peter Høngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner". Naarden. |
2022-07-20 |
| Fountain Healthcare Partners. (11/2/20). "Press Release: Fountain Healthcare Partners Announces Final Close of €125 Million for Fund III". |
2020-11-02 |
| Fountain Healthcare Partners. (5/23/19). "Press Release: Fountain Healthcare Partners Raises €118M for Third Fund. Fund Raise Exceeds Target of €100m". Dublin & New York, NY. |
2019-05-23 |
| Genomics Medicine Ireland Ltd.. (11/27/18). "Press Release: $400 Million Investment Programme Positions Ireland for Global Leadership in Genomic Research and Advanced Life Sciences". |
2018-11-27 |
| Genomics Medicine Ireland Ltd.. (11/6/18). "Press Release: GMI Appoints Dr. Anne Jones as CEO". |
2018-11-06 |
| Genomics Medicine Ireland Ltd.. (11/7/18). "Press Release: GMI Genomics Centre Awarded CAP-Accreditation". |
2018-11-07 |
| Genomics Medicine Ireland Ltd.. (12/11/17). "Press Release: Genomics Medicine Ireland Research Study Aims to Unlock Answers to MS". Cork. |
2017-12-11 |
| Genomics Medicine Ireland Ltd.. (3/30/17). "Press Release: Genomics Medicine Ireland Announces Two Appointments to Its Board. Dr. Kari Stefánsson and Dr. Paul Saunders Appointed to the Board". Dublin. |
2017-03-30 |
| Genomics Medicine Ireland Ltd.. (8/12/19). "Press Release: Genomics Medicine Ireland Announces Strategic Advisory Board". |
2019-08-12 |
| Genomics Medicine Ireland Ltd.. (8/30/18). "Press Release: Genomics Medicine Ireland and University of Cambridge Announce Multiple Sclerosis Research Collaboration". Dublin. |
2018-08-30 |
| GlaxoSmithKline plc. (7/24/17). "Press Release: Phase II Study Results Showed Comparable Viral Suppression Rates at 96 Weeks for a Two-drug Regimen of Long-acting Cabotegravir and Rilpivirine and a Three-drug Regimen in Patients with HIV". |
2017-07-24 |
| HiberGene Diagnostics Ltd.. (4/12/17). "Press Release: HiberGene Closes €6.7m Series B Funding Round". Dublin. |
2017-04-12 |
| Horizon Therapeutics plc. (1/21/20). "Press Release: FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)". Dublin. |
2020-01-21 |
| Horizon Therapeutics plc. (2/1/21). "Press Release: Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio". Dublin & Gaithersburg, MD. |
2021-02-01 |
| Hovione. (11/11/21). "Press Release: Hovione Invests $170 Million in New Capacity and Capabilities". Milan. |
2021-11-11 |
| Inflazome Ltd.. (11/19/18). "Press Release: Inflazome Completes €40m ($46m) Series B Financing to Develop NLRP3 Inflammasome Inhibitors to Clinical Proof-of-Concept". Dublin & Cambridge. |
2018-11-19 |
| Inflazome Ltd.. (3/26/20). "Press Release: Inzomelid Completes Phase I Studies and Shows Positive Results in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)". Dublin, Cambridge & Brisbane. |
2020-03-26 |
| Inflazome Ltd.. (7/14/20). "Press Release: FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)". Dublin, Cambridge & Brisbane. |
2020-07-14 |
| Inflazome Ltd.. (9/21/20). "Press Release: Inflazome Announces Acquisition by Roche". Dublin & Cambridge. |
2020-09-21 |
| Inflection Biosciences Ltd.. (4/16/18). "Press Release: Inflection Biosciences and Trinity College Dublin Announce Immuno-Oncology Research Collaboration". Dublin. |
2018-04-16 |
| Iterum Therapeutics Ltd.. (1/5/17). "Press Release: Iterum Announces Sulopenem in Development for Treatment of Gram-Negative, Multi-drug Resistant Infections". Dublin & Chicago, IL. |
2017-01-05 |
| Iterum Therapeutics Ltd.. (5/19/17). "Press Release: Iterum Secures $65 Million in Series B Financing. Funding to Support the Phase 3 Clinical Development of Oral Penem Antibiotic". Dublin & Chicago, IL. |
2017-05-19 |
| Jazz Pharmaceuticals plc. (2/3/21). "Press Release: Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader". Dublin & London. |
2021-02-03 |
| Jazz Pharmaceuticals plc. (8/12/19). "Press Release: Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.". Dublin. |
2019-08-12 |
| Kerry Group plc. (2/15/22). "Press Release: Kerry Announces Significant Strategic Biotechnology Acquisitions". |
2022-02-15 |
| Kintai Therapeutics, Inc.. (5/29/19). "Press Release: Kintai Therapeutics Announces Formation of World-Class Scientific Advisory Board". Cambridge, MA. |
2019-05-29 |
| Life Sciences Partners (LSP). (1/20/21). "Press Release: LSP Leads EUR 21 Million Series B Funding Round in Neurent Medical". Amsterdam. |
2021-01-20 |
| Luxcel Biosciences Ltd.. (2/15/17). "Press Release: Luxcel Biosciences Ltd, Axiogenesis AG and BMG LABTECH GmbH Secure €2.5m European Investment to Develop and Launch Cell Metabolism Analysis Platform: »MetaCell-TM«". Cork. |
2017-02-15 |
| Mallinckrodt plc. (12/26/17). "Press Release: Mallinckrodt to Acquire Sucampo Pharmaceuticals for approximately $1.2 Billion". Staines-upon-Thames & Rockville, MD. |
2017-12-26 |
![[LSUK] Life-Sciences-UK.com - The UK Life Sciences Web Portal](/images/basics/lsuk-life-sciences-uk-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
